Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy

Cancer statistics, 2016

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Cancer Cell Metabolism: Warburg and Beyond

Peggy P. Hsu, David M. Sabatini · Cell · 2008 · 2.5K citations · Full text

Life Sciences, Cancer Biology, Cell Biology +12

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

Medicine, Gynecology, Oncology +17

Requirement for ERK Activation in Cisplatin-induced Apoptosis

Xiantao Wang, Jennifer L. Martindale, Nikki J. Holbrook · Journal of Biological Chemistry · 2000 · 675 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

Brent C. Behrens, Thomas C. Hamilton, Hidetaka Masuda et al. · PubMed · 1987 · 500 citations

Medicine, Oncology, Pharmacology +17